Comparison of Three Triple Therapies in the Eradication of Helicobacter pylori

  • G. Daskalopoulos
Conference paper


The eradication of Helicobacter pylori infection has proved difficult. As with other chronic infections, evasion of the immune response may be a major factor contributing towards the persistence of infection and the difficulty in eradication with antimicrobials. Although H. pylori can be suppressed with single antibiotic therapy, recrudesence of the infection following the cessation of treatment is the rule [1, 2]. This occurs despite a high in vitro sensitivity of H. pylori to various single antibiotics [3] and apparent therapeutic mucosal antibiotic levels [4, 5]. The resistence to antibiotic therapy may be due to (a) diminished antibiotic activity in the acid environment of the stomach; (b) the development of resistent forms of H. pylori; and (c) the antibiotics not reaching the bacteria in its protected niche under the mucous layer. It is obviously difficult to determine if an antibiotic has reached a precise niche [4]; however, adequate therapeutic mucosal antibiotic levels appear to have been achieved. This would seem to suggest that lack of assistance from an immune response may be a significant factor in failure of single antibiotic therapy.


Triple Therapy Eradication Rate Urea Breath Test Rapid Urease Testing Triple Therapy Regimen 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Langenberg W, Rauws EAJ, Houthoff HJ, Oudbier JH, Widjojokosumo A, Tytgat GJN, Zanen HC (1987) Follow up of Campylobacter pyloridis associated gastritis after treatment with amoxacillin and/or colloidal bismuth subcitrate. In: Kaijser B, Falsen E (eds) Campylobacter, Vol 4. University of Göteborg, Göteborg, pp 366–367Google Scholar
  2. 2.
    Hirschl AM, Pletschette M (1989) Antibiotic treatment of Campylobacter pylori infection. In: Rathbone BJ, Heatly RV (eds) Campylobacter pylori and gastroduodenal disease. Balckwell, Oxford, pp 217–224Google Scholar
  3. 3.
    McNulty CAM, Dent JC (1988) Susceptibility of Campylobacter pylori to twenty-one antimicrobial agents. Eur J Clin Microbiol Infect Dis 7:566–569PubMedCrossRefGoogle Scholar
  4. 4.
    McNulty CAM, Dent JC, Ford GA, Wilkinson SP (1988) Inhibitory antimicrobial concentrations against Campylobacter pylori in gastric mucosa. J. Antimicrob Chemother 22:729–738PubMedCrossRefGoogle Scholar
  5. 5.
    Westblom TU, Duriex DE, Madan E, Belshe RB (1990) Guinea pig model for antibiotic transport across gastric mucosa: inhibitory tissue concentrations of clindamycin against Helicobacter pylori (Campylobacter pylori) following two separate dose regimens. Antimicrob Agents Chemother 34/1:25–28Google Scholar
  6. 6.
    Borody T, Cole P, Noonan S, Morgan A, Ossip G, Maysey J, Brandi S (1988) Long term Campylobacter recurrence post-eradication. Gastroenterology 94 : A43.Google Scholar
  7. 7.
    Shungu DL, Nalin DR, Gilman RH, Gadebusch HH, Cerami AT, Gill C, Weissberger (1987) Comparative susceptibilities of Campylobacter pylori to norfloxacin and other agents. Antimicrob Agents Chemother 31:949–950PubMedGoogle Scholar
  8. 8.
    Mertens JCC, Dekker W, Ligtvoet EEJ, Blok P (1989) Treatment failure of norfloxacin against Campylobacter pylori in patients with nonulcerative dyspepsia. Antimicrob Agents Chemother 33:256–257PubMedGoogle Scholar
  9. 9.
    Glupczynski Y, Lubbe M, Vanderlinden MP, Nyst JF (1989) Lack of antibiotic compliance in patients treated for Campylobacter pylori — associated gastritis. Am J Gastroenterol 84/9:1060–1064Google Scholar
  10. 10.
    Becx MCJM, Jansen AJHM, Clusener HAL, DeKoning RW (1990) Metronidazole-resistant Helicobacter pylori. Lancet 335 (8688): 539–540PubMedCrossRefGoogle Scholar
  11. 11.
    Glupczynski Y, Burette A, De Koster E, Nyst JF, Deltenre M, Cadranel S, Bourdeaux L, De Vos D (1990) Metronidazole resistance in Helicobacter pylori. Lancet 335 (8695): 976–977PubMedCrossRefGoogle Scholar
  12. 12.
    Goodwin CS, Marshall BJ, Blincow ED, Wilson DH, Blackbourn S, Phillips M (1988) Prevention of nitriomidazole resistance in Campylobacter pylori by coadministration of bismuth subcitrate: clinical and in vitro studies. J. Clin Pathol 41:207–210PubMedCrossRefGoogle Scholar
  13. 13.
    Weil J, Bell GD, Jones PH, Gant P, Trowell JE, Harrison G (1988) Eradication of Campylobacter pylori: are we being misled? Lancet 2:1245PubMedCrossRefGoogle Scholar
  14. 14.
    Rauws EAJ, Langenberg W, Houthoff HJ, Zanen HC, Tytgat GNJ (1988) Campylobacter pyloridis — associated chronic active gastritis. Gastroenterology 94:33–40PubMedGoogle Scholar
  15. 15.
    Logan RPH, Gummett PA, Poison RJ, Walker MM, Baron JH, Misiewicz J (1990) The recurrence of H. pylori in relation to duodenal ulcer. Gastroduodenal pathology and Helicobacter pylori. Rev Esp Enferm Dig 78 [Supp 1]: 72Google Scholar
  16. 16.
    Otto G, Fox JG, Wu PY, Taylor NS (1990) Eradication of Helicobacter mustelae from the ferret stomach: an animal model of Helicobacter (Campylobacter) pylori chemotherapy. Antimicrob. Agents Chemother 34/6:1232–1236Google Scholar
  17. 17.
    Gottfried MR, Washington K, Harrell LJ (1990) Helicobacer pylori-like microorganisms and chronic active gastritis in ferrets. Am J Gastroenterol 85/7:813–818Google Scholar
  18. 18.
    Lambert JR, Borromeo M, Pinkard KJ, Turner H, Chapman CB, Smith ML (1987) Colonization of gnotobiotic piglets with Campylobacter pyloridis- an animal model? J Infect Dis 155:1344PubMedCrossRefGoogle Scholar
  19. 19.
    Radin MJ, Eaton KA, Krakowka S, Morgan DR, Lee A, Otto G, Fox J (1990) Helicobacter pylori gastric infection in gnotobiotic beagle dogs. Infect Immun 58/8:2606–2612Google Scholar
  20. 20.
    Engstrand L, Gustavsson S, Jorgensen A, Schwan A, Scheynius A (1990) Inoculation of barrier-born pigs with Helicobacter pylori: a useful animal model for gastritis type B. Infect Immun 58/6:1763–1768Google Scholar
  21. 21.
    Baskerville A, Newell DG (1988) Naturally occurring chronic gastritis and C. pylori infection in the rhesus monkey: a potential model for gastritis in man Gut 29:465–472PubMedCrossRefGoogle Scholar
  22. 22.
    Bell GD, Weil J, Harrison G et al. (1987) 14C-Urea breath analysis, a non-invasive test for Campylobacter pylori in the stomach. Lancet i: 1367–1368CrossRefGoogle Scholar
  23. 23.
    Marshall BJ, Surveyor I (1988) Carbon-14 urea breath test for the diagnosis of Campylobacter pylori associated gastritis. J. Nucl Med 29:11–16PubMedGoogle Scholar
  24. 24.
    Graham DY, Klein PD, Evans DJ, Evans DG, Alpert LC, Opekun AR, Boutton TW (1987) Campylobacter pyloridis detected by the 13C–urea test. Lancet i: 1174–1177CrossRefGoogle Scholar
  25. 25.
    Ribeiro CD, Gray SJ (1987) Long term freeze storage of Campylobacter pyloridis. J. Clin Pathol 40:1265PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1993

Authors and Affiliations

  • G. Daskalopoulos
    • 1
  1. 1.Marrickville Endoscopy CentreMarrickvilleAustralia

Personalised recommendations